Advertisement

Topics

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

08:54 EDT 11 Sep 2017 | ecancermedicalscience

Prof Ledermann speaks with ecancer at the ESMO 2017 Congress about the phase III ARIEL3 study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma. He states that rucaparib has anti-tumour activity...

Original Article: ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

NEXT ARTICLE

More From BioPortfolio on "ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...